Direct-to-consumer pharmacogenomic testing is associated with increased physician utilisation

Journal of Medical Genetics

Volumn 51, Issue 2, 2014, Pages 83-89

  Bloss, Cinnamon S ^a   Schork, Nicholas J ^a,b   Topol, Eric J ^a,b,c  

^a SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONSUMER GENOMICS; DIRECT-TO-CONSUMER; GENETIC TESTING; GENOMIC RISK ASSESSMENT; PERSONALIZED MEDICINE;

ADULT; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOME, HUMAN; HUMANS; MALE; MIDDLE AGED; PATIENT PARTICIPATION; PHARMACOGENETICS; PHYSICIAN'S PRACTICE PATTERNS; SEQUENCE ANALYSIS, DNA;

EID: 84894062097     PISSN: 00222593     EISSN: 14686244     Source Type: Journal    
DOI: 10.1136/jmedgenet-2013-101909     Document Type: Article

References (33)

1. Navigenics. http://www.navigenics.com/ (accessed 1 Jul 2011).
2. 23andMe. https://www.23andme.com/ (accessed 1 Jul 2011).
3. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, Sulkowski M, McHutchison JG, Goldstein DB. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009;461:399-401.
4. McCormack M, Alfirevic A, Bourgeois S, Farrell JJ, Kasperaviciute D, Carrington M, Sills GJ, Marson T, Jia X, de Bakker PI, Chinthapalli K, Molokhia M, Johnson MR, O'Connor GD, Chaila E, Alhusaini S, Shianna KV, Radtke RA, Heinzen EL, Walley N, Pandolfo M, Pichler W, Park BK, Depondt C, Sisodiya SM, Goldstein DB, Deloukas P, Delanty N, Cavalleri GL, Pirmohamed M. HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med 2011;364:1134-43.
5. Chen P, Lin JJ, Lu CS, Ong CT, Hsieh PF, Yang CC, Tai CT, Wu SL, Lu CH, Hsu YC, Yu HY, Ro LS, Lu CT, Chu CC, Tsai JJ, Su YH, Lan SH, Sung SF, Lin SY, Chuang HP,Huang LC, Chen YJ, Tsai PJ, Liao HT, Lin YH, Chen CH, Chung WH, Hung SI, Wu JY, Chang CF, Chen L, Chen YT, Shen CY. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. N Engl J Med 2011;364:1126-33.
6. Brunham LR, Hayden MR. Medicine. Whole-genome sequencing: the new standard of care? Science (New York, NY 2012;336:1112-3.
7. Brenner K. 23andMe wants to change the face of health care. Fortune 12 December 2012.
8. Bloss CS, Ornowski L, Silver E, Cargill M, Vanier V, Schork NJ, Topol EJ. Consumer perceptions of direct-to-consumer personalized genomic risk assessments. Genet Med 2010;12:556-66.
9. Bloss CS, Schork NJ, Topol EJ. Effect of direct-to-consumer genomewide profiling to assess disease risk. The N Engl J Med 2011;364:524-34.
10. Dorn SD, Farley JF, Hansen RA, Shah ND, Sandler RS. Direct-to-consumer and physician promotion of tegaserod correlated with physician visits, diagnoses, and prescriptions. Gastroenterology 2009;137:518-24, 24 e1-2.
11. SurveyMonkey. http://www.surveymonkey.com/ (accessed 27 Jul 2011).
12. Bloss CS, Topol EJ, Schork NJ. Association of direct-to-consumer genome-wide disease risk estimates and self-reported disease. Genet Epidemiol 2011;36:66-70.
13. Spielberger CD, Gorsuch RL, Lushene PR, Vagg PR, Jacobs AG. Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto: Consulting Psychologists Press, Incorporated, 1983.
14. Creamer M, Bell R, Failla S. Psychometric properties of the Impact of Event Scale- Revised. Behav Res Ther 2003;41:1489-96.
15. Ritter PL, Stewart AL, Kaymaz H, Sobel DS, Block DA, Lorig KR. Self-reports of health care utilization compared to provider records. J Clin Epidemiol 2001;54:136-41.
16. Lauerman J. Life Technologies Buys Navigenics for Genetic Diagnostics. Bloomberg News 16 July 2012.
17. Cameron LD, Sherman KA, Marteau TM, Brown PM. Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests. Health Psychol 2009;28:307-16.
18. VassarStats: Website for Statistical Computation. http://vassarstats.net/propdiff_ind. html (accessed 15 May 2012).
19. Machlin SR, Kress M. Trends in Health Care Expenditures for Adults Ages 18-44: 2006 versus 1996. Agency for Healthcare Research and Quality, 2009.
20. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. Jama 1997;277:301-6.
21. Healy M. As genetic testing races ahead, doctors are left behind. Los Angeles Times October 2009.
22. Scheuner MT, Sieverding P, Shekelle PG. Delivery of genomic medicine for common chronic adult diseases: a systematic review. Jama 2008;299:1320-34.
23. Haga S, Burke W, Ginsburg G, Mills R, Agans R. Primary care physicians' knowledge of and experience with pharmacogenetic testing. Clin Genet 2012;82:388-94.
24. Patay BA, Topol EJ. The unmet need of education in genomic medicine. Am J Med 2012;125:5-6.
25. Reid RJ, McBride CM, Alford SH, Price C, Baxevanis AD, Brody LC, Larson EB. Association between health-service use and multiplex genetic testing. Genet Med 2012;14:852-9.
26. Darst BF, Madlensky L, Schork NJ, Topol EJ, Bloss CS. Characteristics of Genomic Test Consumers Who Spontaneously Share Results With Their Health Care Provider. Health Commun 2013;29:105-8.
27. Roberts ME, Riegert-Johnson DL, Thomas BC. Self Diagnosis of Lynch Syndrome Using Direct to Consumer Genetic Testing: A Case Study. J Genet Couns 2011;20:327-9.
28. Janssens AC, Henneman L, Detmar SB, Khoury MJ, Steyerberg EW, Eijkemans MJ, Mushkudiani N, Oostra BA, van Duijn CM, Mackenbach JP. Accuracy of self-reported family history is strongly influenced by the accuracy of self-reported personal health status of relatives. J Clin Epidemiol 2012;65:82-9.
29. Public Health Genomics: Translating Genomics, Family History Public Health Initiative. Centers for Disease Control and Prevention, 2011. http://www.cdc.gov/genomics/famhistory/famhist.htm (accessed 9 Feb 2013).
30. Green RC, Roberts JS, Cupples LA, Relkin NR, Whitehouse PJ, Brown T, Eckert SL, Butson M, Sadovnick AD, Quaid KA, Chen C, Cook-Deegan R, Farrer LA. Disclosure of APOE genotype for risk of Alzheimer's disease. N Engl J Med 2009;361:245-54.
31. Heshka JT, Palleschi C, Howley H, Wilson B, Wells PS. A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genet Med 2008;10:19-32.
32. Crews KR, Cross SJ, McCormick JN, Baker DK, Molinelli AR, Mullins R, Relling MV, Hoffman JM. Development and implementation of a pharmacist-managed clinical pharmacogenetics service. Am J Health Syst Pharm 2011;68:143-50.
33. Janssens AC, Kraft P. Research Conducted Using Data Obtained through Online Communities: Ethical Implications of Methodological Limitations. PLoS Med 2012;9: e1001328.